Mt Olympus Medical Research LLC
Welcome,         Profile    Billing    Logout  
 0 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Thakkar, Harish
FORCE2, NCT05292586: A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared to CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid

Active, not recruiting
3
580
US
Beclomethasone Dipropionate/Formoterol Fumarate, BDP/FF, Beclomethasone Dipropionate, BDP
Chiesi Farmaceutici S.p.A.
Asthma
06/24
06/24
NCT05490680: A New Sildenafil Oral Film in Patients With Erectile Dysfunction

Recruiting
3
488
US
Sildenafil Oral Film 25 mg, 50 mg, 75 mg or 100 mg, Sildenafil Orodispersible Film, Placebo, Placebo-controlled
IBSA Institut Biochimique SA
Erectile Dysfunction
10/24
12/24
NCT04627272: AutoDx-DR Prospective Clinical Validation Study Protocol

Not yet recruiting
N/A
1539
NA
AutoDX-DR
Hill-Rom, Rho, Inc., ClinEdge
Diabetic Retinopathy
07/21
07/21
NCT05808699: Camera Qualification Study

Active, not recruiting
N/A
565
US
handheld fundus camera
Digital Diagnostics, Inc., Fortrea
Diabetic Retinopathy
03/24
11/24
Espinoza, Carina
SCALP2, NCT05914805: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

Recruiting
3
726
Europe, US
Clascoterone 5% solution, CB-03-01 5% solution, Vehicle solution, Vehicle
Cassiopea SpA, Ergomed PLC, Pharmapace Inc, Canfield Scientific Inc., ICON Clinical Research
Alopecia, Androgenetic
08/24
03/25
NCT05772520: The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis

Recruiting
2
120
US
TLL018 tablets, TLL018 Placeboes
Hangzhou Highlightll Pharmaceutical Co., Ltd
Plaque Psoriasis
04/24
05/24
NCT06393452: Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

Recruiting
2
60
US
PP405 0.05% Topical Gel, PP405 Topical Vehicle Gel
Pelage Pharmaceuticals, Inc.
Androgenetic Alopecia
12/24
02/25

Download Options